FYCOMPA susp 0.5 mg/ml buvable fl 340 ml

7680676650018 CH-67665 N03AX22 01.07.1.
FYCOMPA susp 0.5 mg/ml buvable fl 340 ml
FYCOMPA susp 0.5 mg/ml buvable fl 340 ml
FYCOMPA susp 0.5 mg/ml buvable fl 340 ml
1 / 3
google

Details

Product number
6766501
CPT
-
Packaging group
340
Unit
ml
Composition
perampanelum anhydricum 0.5 mg, sorbitolum liquidum cristallisabile corresp. sorbitolum 175 mg, cellulosum microcristallinum, carmellosum natricum, poloxamerum 188, dimeticonum, polysorbatum 65, methylcellulosum, silica colloidalis hydrica, macrogoli stearas, E 210 < 0.005 mg, E 200, acidum sulfuricum, acidum citricum, E 211 1.1 mg, aqua purificata q.s. ad suspensionem pro 1 ml corresp. natrium max. 0.474 mg.

Articles (1)

Fycompa 0.5 mg / mL, Suspension zum Einnehmen
suspension
340
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
175.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.1 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
67665
Drug name
Fycompa, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
N03AX22
Authorization status
Z
Dispensation category
B
First authorization
16/04/2020
Authorization expiration date
31/12/9999
IT number
01.07.1.
Domain
Human medicine
Field of application
Antiepileptikum

Packaging details

Description (FR)
FYCOMPA susp 0.5 mg/ml buvable fl 340 ml
Description (DE)
FYCOMPA Susp 0.5 mg/ml zum Einnehmen Fl 340 ml
Market launch
16/04/2020
Narcotic (BTM)
No